Concentrix Corp
For the period ended Aug 31, 2024. Filed Oct 4, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Aug 31, 2024 · Filed Oct 4, 2024
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2024-05-31; filed 2024-07-05.
0001803599-24-000130
Item 1A. Risk FactorsUnregistered Sales of Equity ecurities and Use of ProceedsOther InformationCurrent report: 10-Q
Period ended 2024-08-31; filed 2024-10-04.
0001803599-24-000156
Item 1A. Risk FactorsUnregistered Sales of Equity ecurities and Use of ProceedsOther InformationThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 9 previous paragraphs and 8 current paragraphs.
6 unchanged; 2 reworded; 0 added; 0 removed; 1 previous and 0 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Reworded paragraphs (2)
Previous wording
The following table summarizes the Company’s purchases of common stock under the share repurchase program during the fiscal quarter ended May 31, 2024:
Current wording
The following table summarizes the Company’s purchases of common stock under the Company’s share repurchase program during the fiscal quarter ended August 31, 2024:
Previous wording
In September 2021, our board of directors authorized the Company to purchase up to $500 million of the Company’s outstanding shares of common stock from time to time as market and business conditions warrant, including through open market purchases or Rule 10b5-1 trading plans. The repurchase program has no termination date and may be suspended or discontinued at any time.
Current wording
(2) Includes shares repurchased as part of the Company’s share repurchase program initiated in September of 2021, under which the Company’s board of directors authorized the Company to purchase up to $500 million of the Company’s outstanding shares of common stock. The repurchase program has no termination date and may be suspended or discontinued at any time.
Rearranged previous paragraphs (1)
Previous report — wording carried elsewhere
(2) Includes shares repurchased as part of the Company’s share repurchase program initiated in September of 2021.